文献速递肿瘤 PET/CT

肺癌PET/MRI中基于MR的衰减图可重复性及其对PET定量的影响

Reproducibility of MR-Based Attenuation Maps in PET/MRI and the Impact on PET Quantification in Lung Cancer.
PubMed 文献 · J Nucl Med · 2017-11-09

本研究评估了现有厂商提供的胸部MR衰减校正(MR-AC)图质量,并探讨其对非小细胞肺癌患者18F-FDG PET定量的可重复性影响。11例患者接受2-5次胸部PET/MRI重复扫描,共90幅MR-AC图用于分析。结果显示86%的MR-AC图存在伪影,30%被主观认为可能影响肿瘤SUV;SUVmean和SUVmax的变异系数分别为5.6%和6.6%,95%的重复扫描SUV变化在±20%以内,主要变异见于受呼吸运动影响的扫描。结论认为MR-AC伪影频发,影响PET/MRI的可重复性,可能导致系列研究中SUV测量不一致,从而可能影响疗效反应评估的可靠性。

要点

  • 86%的胸部MR-AC图存在伪影,30%被主观认为可能影响肿瘤SUV。
  • SUVmean和SUVmax的变异系数分别为5.6%和6.6%。
  • 95%的重复扫描SUV变化在±20%以内,主要变异见于受呼吸运动影响的扫描。

核心结论

  • 标准胸部MR-AC图中伪影频发,影响PET/MRI的可重复性。
  • 伪影与其他已知误差源共同导致系列研究中SUV测量不一致,可能影响疗效反应评估的可靠性。
  • 对胸部MR-AC图及其Dixon图像进行仔细视觉检查,对于发现可能影响SUV可靠性的MR-AC伪影仍然至关重要。

研究设计与样本

  • 11例不可手术的非小细胞肺癌患者,在22天内接受2-5次胸部PET/MRI重复扫描。
  • 每次检查采集18F-FDG PET数据及2幅Dixon MR-AC图,使用相同PET发射数据但不同MR-AC图重建两幅PET图像(PETA和PETB)。
  • 共90幅MR-AC图由2名具有PET/MRI经验的医师进行视觉质量评估和伪影分类。
  • 在PETA上以最大值的40%等轮廓勾画肿瘤感兴趣区,并投影至对应PETB,评估SUVmean和SUVmax。
  • 采用检查内变异系数和Bland-Altman分析评估PETA与PETB间的SUV变化。

主要发现

  • 86%的MR-AC图观察到图像伪影,30%的MR-AC图被主观认为可能影响肿瘤SUV。
  • SUVmean和SUVmax的变异系数分别为5.6%和6.6%。
  • 重复扫描SUV变化在95%的病例中位于±20%以内。
  • 显著的SUV变化主要见于受呼吸运动影响的重复扫描检查。

关键数值与推荐

  • SUVmean变异系数为5.6%,SUVmax变异系数为6.6%。
  • 95%的病例重复扫描SUV变化在±20%以内。
  • 86%的MR-AC图存在伪影,30%被主观认为可能影响肿瘤SUV。

临床怎么用

  • 对胸部MR-AC图及其Dixon图像进行仔细视觉检查,以发现可能影响SUV可靠性的MR-AC伪影。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Quantitative PET/MRI is dependent on reliable and reproducible MR-based attenuation correction (MR-AC). In this study, we evaluated the quality of current vendor-provided thoracic MR-AC maps and further investigated the reproducibility of their impact on 18F-FDG PET quantification in patients with non-small cell lung cancer. Methods: Eleven patients with inoperable non-small cell lung cancer underwent 2-5 thoracic PET/MRI scan-rescan examinations within 22 d. 18F-FDG PET data were acquired along with 2 Dixon MR-AC maps for each examination. Two PET images (PETA and PETB) were reconstructed using identical PET emission data but with MR-AC from these intrasubject repeated attenuation maps. In total, 90 MR-AC maps were evaluated visually for quality and the occurrence of categorized artifacts by 2 PET/MRI-experienced physicians. Each tumor was outlined by a volume of interest (40% isocontour of maximum) on PETA, which was then projected onto the corresponding PETB SUVmean and SUVmax were assessed from the PET images. Within-examination coefficients of variation and Bland-Altman analyses were conducted for the assessment of SUV variations between PETA and PETBResults: Image artifacts were observed in 86% of the MR-AC maps, and 30% of the MR-AC maps were subjectively expected to affect the tumor SUV. SUVmean and SUVmax resulted in coefficients of variation of 5.6% and 6.6%, respectively, and scan-rescan SUV variations were within ±20% in 95% of the cases. Substantial SUV variations were seen mainly for scan-rescan examinations affected by respiratory motion. Conclusion: Artifacts occur frequently in standard thoracic MR-AC maps, affecting the reproducibility of PET/MRI. These, in combination with other well-known sources of error associated with PET/MRI examinations, lead to inconsistent SUV measurements in serial studies, which may affect the reliability of therapy response assessment. A thorough visual inspection of the thoracic MR-AC map and Dixon images from which it is derived remains crucial for the detection of MR-AC artifacts that may influence the reliability of SUV.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Olin A, Ladefoged CN, Langer NH, et al. Reproducibility of MR-Based Attenuation Maps in PET/MRI and the Impact on PET Quantification in Lung Cancer. J Nucl Med. 2017. PMID: 29123008. doi:10.2967/jnumed.117.198853

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。